Written question asked by Stuart Andrew (Conservative) on Monday, 2 February 2015, in the House of Commons. It was due for an answer on Thursday, 5 February 2015 (named day). It was answered by Jane Ellison (Conservative) on Thursday, 5 February 2015 on behalf of the Department of Health.
Meningitis: Vaccination
- Question
-
To ask the Secretary of State for Health, what steps he is taking to ensure progress on price negotiations with Novartis for the Meningitis B vaccine.
- Answer
-
We are seeking to reach a positive conclusion to the negotiations with Novartis for supply of the meningococcal B (MenB) vaccine, Bexsero® at a cost-effective price, as recommended by the Joint Committee on Vaccination and Immunisation as soon as possible. The introduction of an NHS MenB immunisation programme for infants will depend on the outcome of these negotiations.
Secondary information
- Type
- Written question
- Reference
- 222863
- Session
- 2014-15
- Related items
- Grouped for answer
- Yes
- Subjects
- Prices Vaccination Meningitis Novartis
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2022-11-28 15:10:32 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2014-15/222863
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2014-15/222863
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2014-15/222863